text:
Home Authors
Jump to author with a last name starting with:
Roshini Abraham Associate Chief of Academic Affairs and Founding Director of the Diagnostic Immunology Laboratory in the Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH
Charles Abrams, MD Professor of medicine, pathology, and laboratory medicine; vice chair for research; and chief scientific officer of the Department of Medicine at the University of Pennsylvania; director of the Blood Center for Patient Care & Discovery at the University of Pennsylvania and Children's Hospital of Philadelphia; 2016 president of the American Society of Hematology
Anjali Advani Staff Physician in the Department of Hematologic Oncology and Blood Disorders and Director of the Inpatient Leukemia Program at the Taussig Cancer Institute at Cleveland Clinic
Ranjana Advani Professor of oncology at Stanford University Medical Center and the Saul A. Rosenberg Professor of Lymphoma at Stanford University School of Medicine in California
Hanny Al-Samkari, MD Senior clinical fellow in medicine, Dana-Farber Cancer Institute
Steven Allen, MD Associate chief of hematology at the North Shore – LIJ Cancer Institute and professor of medicine at Hofstra North Shore-LIJ School of Medicine
Jessica Altman Associate professor of medicine in hematology and oncology at Robert H. Lurie Medical Research Center in Chicago
Kenneth Anderson Program director of the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at the Dana-Farber Cancer Institute and Kraft Family Professor of Medicine at Harvard Medical School
Joseph Antin, MD Chief and program director of stem cell transplantation and physician at Dana-Farber Cancer Institute, as well as professor of medicine at Harvard Medical School in Boston, Massachusetts
Jon Aster Professor of Pathology at Harvard Medical School and Associate Pathologist at Brigham and Women's Hospital
Richard Aster Professor of Medicine and Pathology at the Medical College of Wisconsin, a Senior Investigator at Versiti Blood Center of Wisconsin, and the recipient of the ASH 2019 Wallace H. Coulter Award for Lifetime Achievement in Hematology
Michael Auerbach, MD Dr. Auerbach is a clinical professor of medicine at Georgetown University School of Medicine in Washington, DC.
Sherif Badawy, MD, MBBCh Fellow of pediatric hematology, oncology, and stem cell transplant at Ann & Robert H. Lurie Children's Hospital of Chicago at Northwestern University's Feinberg School of Medicine
Elisabeth Battinelli Associate Physician, Brigham and Women's Hospital; Assistant Professor of Medicine, Harvard Medical School
Elisabeth Battinelli, MD, PhD Associate Physician, Brigham and Women's Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts
Kenneth Bauer, MD Professor of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
Lisa Baumann-Kreuziger, MD BloodCenter of Wisconsin, Medical College of Wisconsin in Milwaukee
Lisa Bellini, MD Professor of medicine, vice chair for Education, and Internal Medicine Training program director at the Hospital of the University of Pennsylvania
Joel Bennett, MD Professor of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Edward Benz President and CEO Emeritus, Dana-Farber Cancer Institute; Richard and Susan Smith Distinguished Professor of Medicine, Harvard Medical School
Jesús Berdeja Director of Myeloma Research at Sarah Cannon Research Institute in Nashville, Tennessee
Caroline Berube Clinical Associate Professor, Department of Medicine, Division of Hematology, Stanford University School of Medicine
Catherine Bishop Oncology nurse practitioner at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, DC
Clara Bloomfield Distinguished University Professor, the William G. Pace III Endowed Chair in Cancer Research, and cancer scholar and senior advisor at The Ohio State University Comprehensive Cancer Center
David Blumenthal, MD President of the Commonwealth Fund
Ralph Boccia, MD Dr. Boccia is a clinical associate professor of medicine at Georgetown University School of Medicine in Washington, DC, and founder and medical director of the Center for Cancer and Blood Disorder in Maryland.
Brian Bolwell Chairman of Taussig Cancer Institute and a professor of medicine at the Cleveland Clinic Lerner College of Medicine
Alex Boucher Clinical Fellow, Cancer and Blood Disease Institute, Cincinnati, Ohio
David Bowen Professor of Haematology and Consultant Hematologist, Leeds Teaching Hospital, U.K.
Laurence Boxer, MD Professor emeritus of the Division of Pediatric Hematology/Oncology at the University of Michigan in Ann Arbor
James Bradner Associate director of the Center for the Science of Therapeutics at the Broad Institute and associate professor of medicine at Harvard Medical School in Boston, Massachusetts
Douglas Brandoff, MD Co-director of the Adult Palliative Care Clinic at the Dana-Farber Cancer Institute
Elizabeth Brém, MD Assistant professor of medicine at University of California Irvine Medical Center in Orange, CA
Kevin Brigle Hematology/Oncology Nurse Practitioner, Massey Cancer Center
Robert Brodsky The Johns Hopkins Family Professor of Medicine and Oncology and Director, Division of Hematology at The Johns Hopkins University School of Medicine in Baltimore, MD
George Buchanan, MD Professor of pediatrics and internal medicine at University of Texas Southwestern Medical Center in Dallas, Texas
Jose Bufill, MD Director of the Cancer Genetics Program at Saint Joseph Regional Medical Center in Mishawaka, Indiana, and a partner at Michiana Hematology-Oncology, PC, in South Bend, Indiana
Alan Burnett, MD Head of the department of hematology at the Cardiff University School of Medicine in Cardiff, United Kingdom
Linda Burns, MD National Marrow Donor Program/Be The Match Donor Medical Services and the Medical Director at Health Services Research and the Senior Scientific Director at the Center for International Blood and Marrow Transplant Research in Milwaukee, Wisconsin and president of the American Society of Hematology
James Bussel Professor Emeritus of Pediatrics, Weill Cornell Medical College
Brian Callaghan, MD Assistant professor of neurology at the University of Michigan Health System in Ann Arbor, Michigan
John Camoriano Assistant Professor, Oncology and Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
George Canellos, MD William Rosenberg Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts
Hetty Carraway, MD, MBA Associate Professor, Program Director of Hematology Oncology Fellowship, Cleveland Clinic Taussig Cancer Institute
Spero Cataland, MD Dr. Cataland is a professor of internal medicine at The Ohio State University's Wexner Medical Center.
Larisa Cavallari, PharmD, Associate professor and director of the Center for Pharmacogenomics at the University of Florida College of Pharmacy in Gainesville
Gabriela Cesarman-Maus From the National Cancer Institute in Mexico
John Chapin, MD Assistant professor of medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medical College-New York Presbyterian Hospital in New York City, New York
Aude Chapuis Physician, Seattle Cancer Care Alliance; Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine; Assistant Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Aline Charabaty Associate professor of medicine and director of the IBD Center at MedStar-Georgetown University Hospital in Washington, DC
Ajai Chari Professor of Medicine, Director of Clinical Research in the Multiple Myeloma Program, and Associate Director of Clinical Research, Icahn School of Medicine at Mount Sinai, New York
Richard Childs, MD Dr. Childs is a rear admiral (RADM) in the United States Public Health Service Commissioned Corps, Assistant U.S. Surgeon General, and the clinical director of the National Heart, Lung, and Blood Institute's Division of Intramural Research in the National Institutes of Health.
Curt Civin, MD Professor and director of the Center for Stem Cell Biology & Regenerative Medicine and associate dean for research at the University of Maryland School of Medicine in Baltimore, Maryland
Julia Close Clinical associate professor of medicine and director of the fellowship training program within the Division of Hematology and Oncology at University of Florida in Gainesville
Thomas Coates Dr. Coates is professor of pediatrics at Keck School of Medicine at the University of Southern California in Los Angeles.
Eric Cober, MD Department of Infectious Disease at Cleveland Clinic, Ohio
Robert Cohen, MD Professor of medicine at the University of Cincinnati College of Medicine
Alice Cohen, MD Director, Division of Hematology/Oncology, Training Program Director, Hematology/Oncology, Director, Hemophilia and Thrombosis Treatment Center, Newark Beth Israel Medical Center, Newark, New Jersey
Joseph Conners, MD Clinical director at the Centre for Lymphoid Cancer, BC Cancer Agency, and clinical professor at the University of British Columbia, in Vancouver
Jean Marie Connors, MD Assistant Professor, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
Steven Coutre, MD Professor of medicine in hematology at the Stanford University Medical Center in Stanford, California
Yvonne Datta Yvonne H. Datta, MD is Professor of Medicine and Director of Hematology in University of Minnesota's Division of Hematology, Oncology, and Transplantation.
Matthew Davids, MD Associate Director of the Center for Chronic Lymphocytic Leukemia and an Assistant Professor of Medicine at Harvard Medical School
Faith Davies, MD Professor of Medicine, Myeloma Institute for Research and Therapy, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Michael DeBaun Professor of Pediatrics and Medicine and Vice Chair of Clinical and Translational Research in Pediatrics, Vanderbilt University School of Medicine; Director of the Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease
H. Deeg Fred Hutchinson Cancer Research Center
Michael Deininger, MD, PhD Professor and Chief of Hematology and Hematologic Malignancies
Department of Internal Medicine and the Huntsman Cancer Institute
Thomas DeLoughery Professor of medicine, pathology, and pediatrics in the Division of Hematology and Medical Oncology at Oregon Health and Science University Knight Cancer Institute in Portland
Georgette Dent Associate Professor in the Department of Pathology and Laboratory Medicine and Associate Dean for Student Affairs at the University of North Carolina School of Medicine in Chapel Hill
Amy DeZern, MD, MHS Hematologist and medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and assistant professor of oncology and medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland
John Dick Dr. Dick is a senior scientist at Princess Margaret Cancer Centre, professor in the Department of Molecular Genetics at the University of Toronto, and director of the Program in Cancer Stem Cells at the Ontario Institute for Cancer Research (OICR).
Donna DiMichele Deputy director of the Division of Blood Diseases and Resources at the National Institutes of Health's National Heart, Lung, and Blood Institute
John DiPersio Professor, Department of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia and Stem Cell Biology, Washington University School of Medicine in St. Louis
Clark Distelhorst Dr. Distelhorst is the Charles S. Britton II Professor of Hematology/Oncology at the Case Western Reserve University School of Medicine.
Reed Drews Dr. Drews is associate professor of Medicine at Harvard Medical School; director of the Hematology/Oncology Training Program and assistant director of Education at Beth Israel Deaconess Medical Center.
Todd Druley Washington University School of Medicine
Cindy Dunbar Distinguished Investigator and head of the Molecular Hematopoiesis Section of the National Heart, Lung, and Blood Institute at the National Institutes of Health
Cynthia Dunbar Senior Investigator in the Molecular Hematopoiesis Section at the National Institutes of Health's National Heart, Lung, and Blood Institute
Tamara Dunn Clinical Assistant Professor of Medicine and Director of the Hematology Fellowship Program, Stanford University School of Medicine
Amy Dunn Pediatric hematology/oncology specialist at Nationwide Children's Hospital in Ohio
Brian Durie, MD Attending physician at the Cedars-Sinai Medical Center, Los Angeles, California; Chairman of the International Myeloma Foundation; Chairman of the International Myeloma Working Group
Benjamin Ebert, MD, PhD Brigham and Women's Hospital and Harvard Medical School
Leslie Ellis, MD Associate professor of hematology and oncology at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina
Harry Erba Director of the UAB Hematologic Malignancy Program at the University of Alabama at Birmingham
Beth Faiman, PhD, CNP, PhD Certified nurse practitioner at the Cleveland Clinic in Cleveland, Ohio
Daniel Federman Professor of Medicine (General Medicine), Yale School of Medicine; Associate Chief of Medicine, VA Connecticut Healthcare System
Steven Fein Founder and Medical Director of Heme Onc Call, a nationwide telemedicine-only hematology practice
Flannery Fielding Palliative Medicine Nurse Practitioner at Cleveland Clinic in Cleveland, Ohio.
Maria Figueroa Associate Professor of Human Genetics, Co-Leader of the Cancer Epigenetics Research Program, and Assistant Director for Translational Research at the Sylvester Comprehensive Cancer Center in Miami, Florida
Greg Flaker, MD, FACC Professor of medicine in the Division of Cardiovascular Medicine at the University of Missouri - Columbia
Christopher Flowers Department Chair, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Robert Flumenhaft Professor of Medicine, Harvard Medical School, Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center
Arnold Freedman, MD Professor of Medicine at Harvard Medical School and from the Department of Medical Oncology at the Dana-Farber Cancer Institute in Boston, MA
Jonathan Friedberg Director of the James P. Wilmot Cancer Institute and director of Hematologic Malignancies Clinical Research at the University of Rochester Medical Center in Rochester, New York
Bruce Furie, MD Chief of Hemostasis-Thrombosis and director of the Blood Coagulation and Vascular Biology Training Program at Beth Israel Deaconess Medical Center in Boston, Massachusetts
Robert Gale, MD, PhD Visiting professor of hematology at the Imperial College London, executive director of Clinical Research in Hematology and Oncology at Celgene Corporation, and editorial board member for several scientific journals
Tomas Ganz Molecular Biology Institute, University of California, Los Angeles
David Garcia, MD Professor of medicine at the University of Washington School of Medicine in Seattle, Washington
Judith Gasson Professor and Director Emerita and Senior Advisor to the David Geffen School of Medicine for Research and Innovation, University of California, Los Angeles
Aaron Gerds, MD, MS Aaron Gerds, MD, is Deputy Director for Clinical Research at the Cleveland Clinic Taussig Cancer Institute and Associate Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio.
Morie Gertz, MD Chair, Internal Medicine, Mayo Clinic, Minnesota
Aristoteles Giagounidis Head of the Department of Oncology, Haematology, and Palliative Care, Marien Hospital, Düsseldorf, Germany
Timothy Gilligan, MD, MS Co-director of the Center for Excellence in Healthcare Communication, Cleveland Clinic, Cleveland, Ohio
Gary Gilliland President and director of Fred Hutchinson Cancer Research Center in Seattle, Washington
Brett Giroir Assistant Secretary for Health at the U.S. Department of Health and Human Services
Robert Glassman, MD Dr. Glassman is managing director and vice chairman in the Global Healthcare Investment Banking Group at Credit Suisse.
Amy Goodrich, RN, BSN, MSN, CRNP-AC Nurse practitioner in hematologic malignancies and research associate at Johns Hopkins School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland
Jason Gotlib, MD, MS Professor of Medicine (Hematology) at the Stanford Cancer Institute
Eva Gupta Physician at Florida Cancer Specialists & Research Institute in Tampa, Florida
Jean-Luc Harousseau Medical and Scientific Advisor at the International Myeloma Foundation; founding member of the Intergroupe Francophone du Myélome; Professor of Hematology at the University of Nantes in France (retired)
Lisa Hicks Associate Scientist, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto; ASH Committee on Quality Chair
Katherine High Dr. High is co-founder, president, and chief scientific officer of Spark Therapeutics in Philadelphia.
Cameron Hilton Fourth-year medical student at Cleveland Clinic Lerner College of Medicine
Vincent Ho, MD Clinical director of the Stem Cell Transplantation Program and senior physician at Dana-Farber Cancer Institute, as well as associate professor of medicine at Harvard Medical School in Boston, Massachusetts
Richard Hodes Dr. Hodes is Director of the National Institute on Aging at the National Institutes of Health.
Ronald Hoffman Professor of medicine in hematology and medical oncology at Icahn School of Medicine at Mount Sinai in New York
Jonathan Hoggatt, PhD Dr. Hoggatt is an assistant professor of medicine at Harvard Medical School and assistant professor at the Massachusetts General Hospital Cancer Center and Center for Transplantation Sciences in Boston.
Peter Hokland, MD, DMedSci Clinical professor in the department of hematology at Aarhus University in Denmark
Shernan Holtan Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota Medical School
Mary Horowitz, MD, MS Robert A. Uihlein Jr. Chair in hematologic research and professor of medicine and chief of the Division of Hematology and Oncology at the Medical College of Wisconsin in Milwaukee
Leidy Isenalumhe, MD, MS Clinical Hematology/Oncology Fellow, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Eric Jacobsen, MD Clinical Director, Adult Lymphoma Program, Senior Physician, Assistant Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute
Elaine Jaffe Senior Investigator in the Laboratory of Pathology and Head of the Hematopathology Section at the Center for Cancer Research at the National Cancer Institute
Andra James Professor in the Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology and a consulting professor in the Division of Hematology in the Department of Medicine at Duke University School of Medicine in Durham, North Carolina
Brad Kahl Director of the University of Wisconsin Lymphoma Service and clinical research director for hematologic malignancies for the UW Carbone Cancer Center in Madison, Wisconsin
Marc Kahn, MD, MBA Dean of the University of Nevada, Las Vegas School of Medicine; Member of the oversight working group and former Co-Director for the ASH Medical Educators Institute (MEI)
Matt Kalaycio, MD Chair, Department of Hematology and Medical Oncology at the Cleveland Clinic Tausig Cancer Institute
Prashant Kapoor Assistant Professor of Medicine, Mayo Clinic, Rochester, MN
Lawrence Kass, MD Head of Hematopathology at the MetroHealth System and professor of Pathology and Medicine at Case Western Reserve University School of Medicine in Cleveland, Ohio
Leslie Kean Director, Stem Cell Transplant Center, Dana-Farber Cancer Institute
Armand Keating Director, Cell Therapy Program and Philip S. Orsino Facility for Cell Therapy at Princess Margaret Hospital/Ontario Cancer Institute; Professor of Medicine, Professor at the Institute of Biomaterials and Biomedical Engineering; Director of the Division of Hematology Epstein Chair in Cell Therapy and Transplantation at the University of Toronto
Siobán Keel Associate Professor of Medicine in the Division of Hematology at the University of Washington School of Medicine, and hematologist at the University of Washington Medical Center and the Seattle Cancer Care Alliance
Michael Keng, MD Assistant professor of medicine at the Emily Couric Clinical Cancer Center in the University of Virginia Health System in Charlottesville, Virginia
Jennifer Kesselheim, MD, MEd, MBE Associate Fellowship Program Director for Education and Senior Physician at Dana-Farber Cancer Institute, Assistant Professor of Pediatrics at Harvard Medical School, Co-Director of ASH Medical Educators Institute
Allison King, MD, MPH, PhD Associate Professor, Medical Director, Survivorship Program for Siteman Cancer Center, Program in Occupational Therapy, Departments of Pediatrics and Medicine, Division of Hematology and Oncology, Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Washington University, Saint Louis, MO
Zachary Kiser 2019-2020 ASH Congressional Fellow
Craig Kitchens, MD Professor Emeritus of Medicine, Department of Hematology & Oncology, University of Florida
Jean Koff Instructor of hematology and medical oncology at the Emory University School of Medicine in Atlanta
Jonathan Kolitz Professor of medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; associate chief, Hematologic Oncology, Monter Cancer Center, Lake Success, New York
Barbara Konkle, MD Associate Chief Scientific Officer and Associate Director, Washington Center for Bleeding Disorders; Director, Hemostasis, Platelet Immunology, and Genomics Laboratory, Bloodworks Northwest; Professor of Medicine/Hematology, University of Washington
John Koreth, MBBS DPhil Associate Professor of Medicine, Harvard Medical School
Senior Physician, Dana-Farber Cancer Institute
Michael Kroll, MD Professor of Medicine, Chief of the Section of Benign Hematology, The University of Texas MD Anderson Cancer Center
Rebecca Kruse-Jarres, MD, MPH Director of the Washington Center for Bleeding Disorders at Bloodworks NW and associate professor of medicine in the division of hematology at the University of Washington School of Medicine in Seattle, Washington
Shaji Kumar, MD Professor of medicine at Mayo Clinic College of Medicine in Rochester, Minnesota
Sandra Kurtin, RN, MS Nurse practitioner at the University of Arizona Cancer Center and assistant professor of medicine, and adjunct clinical assistant of nursing at The University of Arizona in Tucson.
Joanne Kurtzberg Dr. Kurtzberg is Director of the Marcus Center for Cellular Cures, Director of the Pediatric Blood and Marrow Transplant Program, Director of the Carolinas Cord Blood Bank, and Co-Director of the Stem Cell Transplant Laboratory at Duke University Medical Center.
Robert Kyle, MD Professor of Laboratory Medicine & Pathology and professor of Medicine at the Mayo Clinic in Rochester, Minnesota
Ann LaCasce, MD, Associate Professor of Medicine, Lymphoma Program, Dana-Farber Cancer Institute
Ola Landgren, MD Professor of medicine and chief of myeloma service at Memorial Sloan Kettering Cancer Center in New York City, New York
Richard Larson, MD Professor of Medicine at the University of Chicago in Chicago, Illinois
Agnes Lee, MD Professor of medicine at the University of British Columbia and director of the thrombosis program at Vancouver General Hospital in British Columbia, Canada
Stephanie Lee, MD, MPH Fred Hutchinson Cancer Research Center in Seattle, Washington
Susan Leitman Director, Medical Research Scholars Program, National Institutes of Health
John Leonard Associate dean for clinical research, vice chairman for clinical research, and associate director of the Cancer Center at Weill Cornell Medical College in New York, New York
Ross Levine Laurence Joseph Dineen Chair in Leukemia Research and director of the Memorial Sloan Kettering Center for Hematologic Malignancies at Memorial Sloan Kettering Cancer Center in New York, New York
Alan Lichtin Department of Hematology and Medical Oncology, Cleveland Clinic
Michaela Liedtke Assistant Professor of Medicine, Stanford University Medical Center, CA
John Lin Abramson Cancer Center at the University of Pennsylvania
Michael Linenberger Professor of medicine in the Division of Hematology, Robert and Phyllis Henigson Endowed Chair in Hematology, and director of the Hematology/Oncology Fellowship Program at the University of Washington School of Medicine in Seattle. Also medical director of apheresis and cellular therapy at the Seattle Cancer Care Alliance and a member of the Fred Hutchinson Cancer Research Center.
Jane Little Professor of Medicine, Division of Hematology and Oncology, UNC School of Medicine; Director, UNC Comprehensive Sickle Cell Disease program
Frederick Locke Coleader of the Immunology Program, Moffitt Cancer Center
Sagar Lonial Chair and Professor, Department of Hematology and Medical Oncology and Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Jennifer Lonzer, MA Editorial project leader at the Cleveland Clinic in Cleveland, Ohio
Alison Loren, MD, MS Fellowship Program Director in the Department of Medicine at the Hospital of the University of Pennsylvania in Philadelphia
Bob Löwenberg, MD, PhD Professor of hematology at Erasmus University Medical Center in Rotterdam, the Netherlands, and the Editor-in-Chief of Blood
Selina Luger, MD Director of the Leukemia Program and professor of medicine at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia
Jennifer Lycette Assistant Professor, Oregon Health & Science University; Hematologist/Oncologist, Columbia Memorial Hospital-Oregon Health & Science University Knight Cancer Collaborative, Astoria, Oregon
Alice Ma, MD Professor of Medicine in the Division of Hematology and Oncology at the University of North Carolina School of Medicine in Chapel Hill
Dwight Macero Mr. Macero is an instructor in the Blood Cancer and Bone Marrow Transplant Program at the University of Colorado Cancer Center.
Navneet Majhail, MD Director of the Blood & Marrow Transplant Program at Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio
Jacques Malherbe, MD Clinical hematologist and head of the clinical hematology division in the department of internal medicine at Universitas Hospital, University of the Free State, in Bloemfontein, South Africa
Hemant Malhotra Head of the Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India
Kandice Marchant Medical Director of Hemostasis & Thrombosis, Cleveland Clinic
Peter Marks Director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research
Ariela Marshall Assistant Program Director, Hematology Fellowship, Mayo Clinic; First-year faculty member for the ASH Medical Educators Institute (MEI)
Robert Massie
Jori May Fellow in the Division of Hematology/Oncology at the University of Alabama at Birmingham
Keith McCrae, MD Staff in Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Department of Cellular and Molecular Medicine (NC10), Cleveland Clinic Lerner Research Institute, Ohio
William Mentzer, MD Professor Emeritus of Pediatrics at the University of California San Francisco
Ruben Mesa, MD Director, UT Health San Antonio MD Anderson Cancer Center
Laura Michaelis, MD Associate professor of medicine in the Division of Hematology and Oncology at the Medical College of Wisconsin in Milwaukee
Saskia Middeldorp Professor of Medicine, Department of Vascular Medicine, Amsterdam University Medical Centers, The Netherlands
Joseph Mikhael, MD, MEd Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center and Chief Medical Officer, International Myeloma Foundation
Beverly Mitchell, MD Director of the Stanford Cancer Institute
Moshe Mittelman Former Chairman of Medicine, Tel Aviv Sourasky Medical Center; Professor of Medicine and Hematology, Tel Aviv University Sackler Medical School; President of the Israel Society of Hematology and Blood Transfusion
Stephan Moll Professor of Medicine in the Division of Hematology and Oncology at the University of North Carolina
Colleen Morton Director of Clinical Coagulation at Regions Hospital, HealthPartners, and an assistant professor in the Department of Hematology, Oncology, and Transplantation at the University of Minnesota in Minneapolis
Charles Mulligan St. Jude Children's Research Hospital Faculty Member; Deputy Director, Comprehensive Cancer Center; Co-Leader, Hematological Malignancies Program; Medical Director, St. Jude Biorepository; William E. Evans Endowed Chair
Martina Murphy Assistant professor of medicine and assistant director of the Hematology/Oncology Fellowship program at the University of Florida College of Medicine in Gainesville; co-director of the UF Obstetric Hematology Clinic
Ralph Nachman, MD Professor emeritus of medicine at Weill Cornell Medicine in New York, New York
Megan Nakashima Academic hematopathologist and Hematopathology Fellowship Director, Cleveland Clinic
Anne Neff, MD Department of Hematology/Medical Oncology at the Cleveland Clinic in Cleveland, Ohio
Marquita Nelson Third-year hematology/oncology fellow, University of Chicago
Cindy Neunert Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Herbert Irving Comprehensive Cancer Center
Darren Nichols Associate professor of family medicine at the University of Alberta in Edmonton, Canada
Pierre Noel Medical Director of Military Medicine, Mayo Clinic, Phoenix, Arizona
Ariela Noy Memorial Sloan-Kettering Cancer Center, New York, NY
Carol O'Hear, MD, PhD Completed her pediatric hematology/oncology fellowship at St. Jude Children's Research Hospital in 2014 and joined Genentech in South San Francisco, California, as an assistant medical director
Olatoyosi Odenike Associate professor of medicine in the hematology/oncology section at the University of Chicago
Danielle Ofri Associate Professor, New York University School of Medicine, New York, NY
Thomas Ortel Professor of Medicine, Chief, Division of Hematology in the Department of Medicine, and Professor of Pathology, Duke University School of Medicine
Ifeyinwa Osunkwo Clinical associate professor of medicine at the University of North Carolina at Chapel Hill and the director of the Sickle Cell Disease Enterprise at Atrium Health's Levine Cancer Institute in Charlotte, North Carolina.
Martin Palmeri, MD Hematologist/oncologist at Cancer Care of Western North Carolina in Asheville
Elli Papaemmanuil Assistant Professor in Computational Oncology, Memorial Sloan Kettering Cancer Center, New York
Samir Parekh Dr. Parekh is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Mrinal Patnaik, MBBS Associate professor of internal medicine and oncology, consultant, Division of Hematology, Mayo Clinic, Rochester, Minnesota
Louis Pelus, PhD Professor of microbiology and immunology in the Department of Microbiology and Immunology at Indiana University School of Medicine in Indianapolis, Indiana
Carrie Peterson Nurse Practitioner at University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center
Todd Pickard, MMSc, PA-C Director of the Physician Assistant Administrative Programs at the University of Texas MD Anderson Cancer Center in Houston, Texas
Allyson Pishko Assistant Professor, Division of Hematology/Oncology, University of Pennsylvania
Uwe Platzbecker Professor of Translational Hematology in the Department of Internal Medicine I and head of the Section of Hematology at the University Hospital Carl Gustav Carus in Dresden, Germany
Dan Pollyea Clinical director of Leukemia Services and associate professor of medicine at the University of Colorado Cancer Center
Carol Portlock, MD Attending, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Josef Prchal The Charles A. Nugent, M.D., and Margaret Nugent Endowed Professor at University of Utah & Huntsman Cancer Center
Jerald Radich Principal investigator of the Radich Lab in the clinical research division at Fred Hutchinson Cancer Research Center, Seattle, Washington
Leslie Raffini Director, Hemostasis and Thrombosis Center, Children's Hospital of Philadelphia, Philadelphia, PA
Margaret Ragni Professor of medicine and clinical translational science at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania
Kanti Rai Joel Finkelstein Cancer Foundation Professor of Medicine and Professor of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York
Anita Rajasekhar, MD Assistant professor of medicine in the Division of Hematology and Oncology at the University of Florida in Gainesville, Florida
Erin Reid Professor of Medicine; Vice Chair, Lymphoma Working Group, Moores Cancer Center, UC San Diego Health
Tiffany Richards, MS, ANP, AOCNP Nurse practitioner in the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center in Houston, Texas
Paul Richardson Medical oncologist at Dana-Farber Cancer Institute in Boston
Marcie Riches, MD, MS Clinical Associate Professor and Director of Clinical Research and Data Quality, BMT in the Division of Hematology/Oncology at the University of North Carolina at Chapel Hill
Jean Ridgeway Advanced Nurse Practitioner in the department of hematology/oncology at the University of Chicago Medical Center in Chicago, Illinois
Allison Rosenthal Dr. Rosenthal is assistant professor of medicine and senior associate consultant in the Division of Hematology/Oncology at Mayo Clinic in Phoenix.
John Ryan, MD, FACC, FAHA Assistant professor in the Department of Internal Medicine at the University of Utah
Ravindra Sarode John H. Childers, M.D. Professorship in Pathology, UT Southwestern Medical Center
Jennifer Saultz, DO Fellow in hematology and medical oncology, The Ohio State University Wexner Medical Center
Michael Savona Professor of Medicine and Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee
Lidia Schapira Associate professor of medicine at the Stanford University Medical Center in Palo Alto, California
David Schenkein Dr. Schenkein is a general partner at GV (formerly Google Ventures), where he coleads the life science investment team, and an adjunct attending physician in hematology at Tufts Medical Center in Boston.
Fred Schiffman, MD Sigal Family Professor of Humanistic Medicine, vice chairman of medicine, and associate physician-in-chief of The Miriam Hospital, as well as associate program director of Categorical and Preliminary Programs in Medicine at the Warren Alpert Medical School of Brown University, and Medical Director of the Lifespan Comprehensive Cancer Center in Providence, Rhode Island
Stanley Schrier, MD Professor of Medicine (Hematology), Active Emeritus at the Stanford School of Medicine in Stanford, California
Anna Schuh Dr. Schuh is the director of the Oxford Molecular Diagnostics Centre, a consultant hematologist at Oxford University Hospitals, and an associate professor in hematology at the University of Oxford.
Bart Scott, MD Assistant Professor of Medicine, Division of Oncology, University of Washington
Director of Hematology and Hematologic Malignancies, Seattle Cancer Care Alliance
Laurie Sehn, MD Medical oncologist at the BC Cancer Agency and clinical associate professor at the University of British Columbia, Canada
Eric Seifter Dr. Seifter is associate professor at the Johns Hopkins University School of Medicine and a hematologist in private practice at Park Medical Associates in Maryland.
Mikkael Sekeres Director of the Leukemia Program at the Cleveland Clinic in Cleveland, Ohio
Jayshree Shah Nurse Practitioner, Regional Cancer Care Associates at Hackensack University Medical Center in New Jersey; Nurse Educator, AstraZeneca
Samantha Shams Physician at Piedmont Cancer Institute in Atlanta
Tait Shanafelt Jeanie and Stewart Ritchie Professor of Medicine, Chief Wellness Officer, and Associate Dean, Stanford University School of Medicine; Director of the Stanford WellMD Center
Norman Sharpless Dr. Sharpless is the director of the National Cancer Institute and is specialized in the care of patients with leukemia.
Joseph Shatzel Fellow at Oregon Health and Science University Knight Cancer Institute in Portland
Joseph Shatzel Dr. Shatzel is a fellow in the Division of Hematology and Medical Oncology at Oregon Health and Science University Knight Cancer Institute in Portland.
Surbhi Sidana, MBBS Third-year Fellow, Hematology/oncology, Mayo Clinic, Rochester, Minnesota
Richard Silver, MD Professor Emeritus of Medicine at Weill Cornell Medical College
Roy Silverstein Chair of the Department of Medicine and Linda and John Mellowes Professor of Medicine, Medical College of Wisconsin; Senior Investigator at the Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee
Sonali Smith, MD Associate Professor of Medicine Director, Lymphoma Program, The University of Chicago Medicine
Mitchell Smith, MD Director of the lymphoid malignancy program at the Cleveland Clinic in Cleveland, Ohio
Gerald Soff, MD Chief of the hematology service, Memorial Sloan Kettering Cancer Center, New York.
Gamini Soori, MD, MBA Vice president of Nebraska Cancer Specialists and a clinical professor of medicine at Creighton University School of Medicine, both in Omaha, Nebraska. Dr. Soori is also chair of the Council on Graduate Medical Education.
Eduardo Sotomayor, MD Director, GW Cancer Center, George Washington University, Washington, DC
Joseph Stavas, MD Professor of radiology at the University of North Carolina School of Medicine in Chapel Hill, North Carolina
David Steensma, MD Edward P. Evans Chair in MDS Research and Institute Physician at the Dana-Farber Cancer Institute; Associate Professor of Medicine at Harvard Medical School; Editor-in-chief of ASH Clinical News
Kimberly Stegmaier Associate professor of pediatrics at Harvard Medical School, vice chair of pediatric oncology research at Dana-Farber Cancer Institute, and co-director of the Pediatric Hematologic Malignancy Program at Boston Children's Hospital and Dana-Farber Cancer Institute
Brady Stein Dr. Stein is assistant professor of medicine in the hematology/oncology division at Northwestern University's Feinberg School of Medicine in Chicago, Illinois.
Keith Stewart, MBChB, MBA Carlson and Nelson Endowed Director, Center for Individualized Medicine, and Vasek and Anna Maria Polak Professor of Cancer Research, Mayo Clinic in Scottsdale, Arizona
Patrick Stiff, MD Division director of hematology/oncology and medical director of the Cardinal Bernadin Cancer Center of Loyola University Medical Center, as well as professor in the departments of hematology/oncology and pathology at Loyola University Chicago Stritch School of Medicine in in Maywood, Illinois
Wendy Stock, MD Professor of medicine in hematology/oncology and director of the Leukemia Program at University of Chicago
Richard Stone, MD Clinical director of the Adult Acute Leukemia Program at the Dana-Farber Cancer Institute in Boston
David Straus, MD David Straus, MD, Internist and Hematologic Oncologist, Memorial Sloan Kettering Cancer Center, New York, New York
John Sweetenham, MD Senior Director of Clinical Affairs, Executive Medical Director, Huntsman Cancer Institute, Salt Lake City, Utah
David Sykes Assistant professor of medicine at Harvard Medical School in Boston, Massachusetts
Michael Sykes Bioinformatics scientist in San Diego, California
Jeffrey Szer Professor of Hematology, The Royal Melbourne Hospital, Australia
Martin Tallman, MD Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center in New York
Joseph Tariman, PhD Assistant professor in nursing at DePaul University's College of Science and Health in Chicago, IL
Ayalew Tefferi Professor of Hematology/Oncology, Mayo Clinic, Rochester, Minnesota
Marilyn Telen Wellcome Professor of Medicine in the Division of Hematology and Director of Duke Comprehensive Sickle Cell Center at Duke University Medical Center in Durham, North Carolina
Karl Theil, MD Hematopathologist and director of the Pathology Residency Program at Cleveland Clinic in Cleveland, Ohio
Swee Thein, MD Dr. Thein is a Senior Investigator and Chief of the Sickle Cell Branch with the National Institutes of Health's National Heart, Lung and Blood Institute.
Angela Thomas, OBE, PhD Dr. Thomas is vice chair of the U.K.'s Commission on Human Medicines. She is a fellow of the Royal College of Physicians of Edinburgh, where she also is the director of heritage and honorary librarian.
Alexis Thompson Dr. Thompson is head of the hematology section of the Division of Hematology Oncology Transplantation at the Ann and Robert H. Lurie Children's Hospital of Chicago and associate director of Equity and Minority Health at Northwestern University.
John Tisdale Senior Investigator in the Molecular and Clinical Hematology Section at the National Institutes of Health
Arthur Topilow Dr. Topilow was formerly director of Hematology/Medical Oncology at the Jersey Shore University Medical Center. Retired from clinical practice, he now runs a premedical student internship, offers guidance for writing medical papers, and has his own liquid biopsy research program.
Nathaniel Treister, DMD, DMSc Assistant professor of Oral Medicine at Harvard School of Dental Medicine and the chief of the divisions of Oral Medicine and Dentistry at Brigham & Women's Hospital in Boston, Massachusetts
Saad Usmani, MD Director of Plasma Cell Disorders Program, Director of Clinical Research in Hematologic Malignancies, Levine Cancer Institute
Geoffrey Uy, MD Associate professor of medicine at the Washington University School of Medicine in St. Louis, Missouri
Abraham Verghese Linda R. Meier and Joan F. Lane Provostial Professor at Stanford Medicine; bestselling author of the 2010 novel Cutting for Stone and other works
Vip Viprakasit, MD, DPhil Dr. Viprakasit is professor of pediatrics in the Department of Pediatrics & Thalassemia Center at Siriraj Hospital at Mahidol University in Bangkok, Thailand. He also is founder of ATGenes, a biotechnology and diagnostic services company in Thailand.
Alison Walker Associate Professor in the Division of Hematology, The Ohio State University
Lukas Wartman Assistant professor in the Department of Medicine in the Division of Oncology at Washington University School of Medicine in St. Louis, Missouri
Jason Westin Dr. Westin is the leader of the diffuse large B-cell lymphoma research team at the University of Texas MD Anderson Cancer Center in the Department of Lymphoma and Myeloma.
Michael Willams, MD Chair of the ABIM's Hematology Specialty Board and an ABIM Council Member, and is the Byrd S. Leavell Professor of Medicine and chief of the Hematology/Oncology Division at the University of Virginia School of Medicine in Charlottesville, Virginia
David Williams, MD President of the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Leland Fikes Professor of Pediatrics at Harvard Medical School and 2015 ASH President
Jane Winter, MD Professor of Medicine
Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center
Division of Hematology/Oncology
Alexandra Wolanskyj-Spinner, MD Professor of Medicine in the Department of Hematology at Mayo Clinic in Rochester, Minnesota; Associate Editor, ASH Clinical News
Alisa Wolberg Professor of Pathology, UNC Blood Research Center
Jennifer Woyach, MD Associate Professor at The Ohio State University Comprehensive Cancer Center
Ted Wun, MD Associate Dean for Research, Chief of the Division of Hematology and OncologyUniversity of California (UC) Davis School of Medicine; Principal Investigator and Director of the UC Davis Clinical and Translational Science Center, Sacramento, California.
Joachim Yahalom, MD Vice chair of academic programs, Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York, New York
Allen Yang Senior Vice President and Chief Medical Officer of Xencor
Guy Young Professor of Pediatrics at the Keck School of Medicine at the University of Southern California
Guy Young Director, Hemostasis and Thrombosis Program, and Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation at Children's Hospital Los Angeles
Neal Young, MD Senior investigator at the National Institutes of Health and chief of the Hematology Branch of the National Heart, Lung, and Blood Institute
Neil Zakai Associate Professor of Medicine, Hematology/Oncology Division, Department of Medicine, Associate Professor of Pathology & Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont
Catherine Zander Postdoctoral fellow in the department of pathology at the University of Alabama at Birmingham School of Medicine
Sandra Zinkel Associate Professor of Medicine and Cell & Developmental Biology, Vanderbilt University
Laura Zitella, MS, RN, ACNP-BC, AOCN Hematology/Oncology Nurse Practitioner, Associate Clinical Professor, University of California San Francisco
Leonard Zon Grousbeck Professor of Pediatrics, Harvard Medical School; Professor of Stem Cell and Regenerative Biology, Harvard University; Stem Cell Program Director, Boston Children's Hospital
Marc Zumberg, MD Section chief of non-malignant hematology in the Division of Hematology/Oncology and the Department of Medicine at the University of Florida Health in Gainesville, Florida


text:
Alex Trebek tribute video released before…
Alex Trebek tribute video released before tonight's final episode
Montage of clips accompanied by the song, 'Once Before I Go'
By Chuck Barney | cbarney@bayareanewsgroup.com | Bay Area News Group
PUBLISHED: January 8, 2021 at 3:15 p.m. | UPDATED: January 12, 2021 at 5:12 a.m.
The tear-inducing video tribute to the late Alex Trebek that will air tonight as part of his final "Jeopardy!" episode has been released by the game show's producers.
The montage of vintage clips — about 90 seconds in length — plays over the sound of Peter Allen's "Once Before I Go."
The clips include archival footage of Trebek's early days on the popular quiz show, including a scene in which he reminds viewers that he "doesn't write the clues." Also included: Shots of him with his children on "family visiting day" and several scenes of the beloved host in various costumes, including a KISS get-up.
Trebek died on Nov. 8, following a public battle with pancreatic cancer. Tonight's episode, which can be seen at 7 p.m. on KGO-TV in the Bay Area, was taped in late October.
Chuck Barney | TV columnist
Chuck Barney is the TV critic and columnist for the Bay Area News Group. He's still in mourning over the cancellation of "Freaks and Geeks."
cbarney@bayareanewsgroup.com
Follow Chuck Barney	BayAreaNewsGroup.ChuckBarney Follow Chuck Barney	@chuckbarney
Tiffany Trump's strange timing to announce 'I'm engaged!'
Vallejo superstar H.E.R. to sing at 2021 Super Bowl in Tampa
How to watch 'The Evil Dead' live with leading man Bruce Campbell
Unlike Ivanka Trump, Ashley Biden doesn't expect a job in dad's White House

redpajama_set_name: RedPajamaCommonCrawl


Ogień is a new Neapolitan-style pizza joint on Pomorska which, despite a few service hiccups, has real potential to be one of the best pizzerias in Wroclaw.
Ogień should have been fuller on a beautiful Wednesday evening in Wroclaw. We've seen pizza projects like Happy Little Truck's Niezły Dym gain enough popularity to open a sit-down location, wood-fired oven and all, and don't get me started on the Italian extravaganza that is Więzienna Street. So I'll begin by saying that if you're looking for above-average pizza and want a local vibe, I'd be happy to recommend this neat little place on Pomorska and Wąska.
It's certainly endearing to see a new restaurant trying to iron out the kinks in its system, though the joke is often on the customer. It would have been nice to be greeted when we walked in the door, and since there was no sign indicating samoobsługa (self-service), it was only after watching other guests that I cottoned to the fact that I was supposed to order at the bar (and pay upfront). This was more than a bit awkward, especially since the server did not feel compelled to prevent me from making my mistakes.
In general, however, service was polite, and willing to accommodate my rather American assumption that I'd be served table-side. I think Ogień just needs some time to decide if it wants the customer or the server to do the work of ordering: either is fine, but one should be chosen to avoid confusion. Anyhow, the service can always be improved, and I'm hopeful that the Ogień family realizes its guests could feel more at home with some attentive waiting staff.
Let's talk about the food. There's no liquor license as of yet, which did not turn out to be problematic as there was a very refreshing, not-too-sweet liter of lemonade on the menu that I gladly quaffed. We ordered the vegan salad to split, which came undressed. After we understood we were supposed to oil-and-vinegar it ourselves (once again, unexplained by our server – maybe she was just shy), it turned out to be bright and unassuming, with high-quality olives, sun-dried tomatoes, and roasted pepitas. A fresh pepper mill would have been a most welcome touch throughout the whole meal.
Now, the pizzas. They are really very good, which is just as well as the prices at Ogień are slightly above average at around 25zł per pie (a Margherita is 18zl,1-3zl more than at Pizzeria Si, Niezły Dym or Piec Na Szewskiej). The dough is clearly made by hand and was very fresh, sweet but with the slight tang of natural fermentation. It was airy and chewy, and both of our pizzas came out with those lovely charred bubbles you can only get from a brick oven.
My one critique on all the pizzas would be that the tomato sauce (DOP San Marzano base) could use some seasoning. The Pepe was essentially an elevated pepperoni pizza, with fresh ricotta and Neapolitan salami (broiled to a crisp at 450°C according to the emphatic menu) complementing each other and working in concert with the dough to provide a rich, satisfyingly savory treat. The Gorgo, with its pile of walnuts and salty, gooey cheesy goodness, was gratifying and excellent (it could be a showstopper if drizzled with honey, but that's just this reviewer's opinion).
Give Ogień some time to smooth out its operations, but don't avoid it. It'll be an even better spot once you can get a bottle of cheap Italian wine, and in winter the oven will make the atmosphere utterly cozy. It's a restaurant with real potential to be fun, and I'd love to see it fill up with happy Wroclawian Neapolitans, so tell your friends. The kinks can only be worked out with customers to practice on, and the pizza is already worth being a guinea pig for. I'll be back myself.
Maia is a half-Polish, half-American pastry chef and long distance hiker who has just moved back to Wroclaw after what feels like a lifetime away. She is constantly looking for new things to see, do, and eat - and wants to share her experiences with fellow English-speaking fans of this fantastic city.


Well, I've put the finishing touches on my Business Buyer Success! program for the fall.
This program uses my Business Buyer Secrets seminar information and breaks it down into small digestible parts, gives you homework and tasks to accomplish and then a one-on-one follow up with me to review.
We then meet back and share among the group to maximize our learning of the material.
During the course, you will conduct a business search, meet professionals that you will use in a purchase and make an offer on a business.
This is your opportunity to arm yourself with the information you need to buy a profitable, mature business and pay the right price while mitigating risk through a proper deal structure.
The whole thing kicks off on September 2 and will finish just before Christmas.
Special pricing offer ends August 2, 2014. If you want to change your life through business ownership, this is the program for you. Program open to US and Canadian residents, pricing in $CAD.


The 'always on' culture and the speed and uncertainty of life today impacts the quality of our lives and relationships as well as our performance at work. Learning how to grow your inner resources can help you to feel calmer, happier, more focused and fulfilled .
Whether you are looking for ways to enhance your personal wellbeing, find a new direction in life or build a flourishing workplace, Be More can help. Offering personal, leadership and wellbeing coaching and training in Buckinghamshire, Oxfordshire and around the world on video conferencing.
TAKE TIME TO REFLECT AND FIND CREATIVE WAYS TO MOVE FORWARD.
DISCOVER HOW TO CULTIVATE PERSONAL WELLBEING.
PRACTICAL WISDOM FOR THE WORKPLACE.


WELCOME TO KROLL PATROL ENGLISH!
Welcome to the 2018-2019 school year! This year, I will be teaching English 9 and English 10. If you are visiting this site, I bet you have me for a teacher. On the top navigation bar, you'll notice there are tabs to go to your specific course. Each course page will have specific information pertaining to the class. This website will keep you posted with what is going on in Room 228 and you'll be able to find class information, projects, assignments, and many other neat things.
If you have any questions, please feel free to e-mail me at: krollji@lc-ps.org.
It is my hope that we have a GREAT semester together!


text:
What's happened to the Santa Ana River homeless…
What's happened to the Santa Ana River homeless people since their motel stays expired?
The fate of the homeless population whose numbers were estimated to be as high as 1,000 people remains central to a civil rights lawsuit filed in late January that eventually led the county to offer 30-day motel stays to 700 people. Above, a homeless encampment under the shadow of the Big A of Angel Stadium in July 2017. (File photo by Bill Alkofer, Orange County Register/SCNG)
By Theresa Walker | thwalker@scng.com | Orange County Register
PUBLISHED: April 4, 2018 at 6:59 p.m. | UPDATED: April 5, 2018 at 10:12 a.m.
It's always the overriding question whenever there is a push to get homeless people off the streets or out of other public places: Where will they go?
When Orange County decided to dismantle the tent encampments at the Santa Ana River Trail, that question was asked by the homeless people, advocates, and the residents and merchants in the neighborhoods of Anaheim and Orange closest to the bike trail.
It remains unanswered in the longer term.
The fate of a homeless population estimated to be as high as 1,000 people remains central to a civil rights lawsuit filed in late January that eventually led the county to offer 30-day motel stays to about 700 people, along with assessments of their needs.
It now has engaged the entire county in considering next steps on emergency shelters, transitional and permanent housing, and how to deal with transients who disrupt communities.
Costs and numbers
The motel program involved 51 motels, at an average cost of $95 per night for 582 rooms, said Jennifer Nentwig, a spokeswoman for the county. That would put the cost for the 30-day program, not including some extended stays, at about $1.6 million.
The county spent another $1.6 million on a six-month contract at an Anaheim motel used for longer-term mental health placements.
The last of the motel stays ended March 28. Earlier this week, Orange County Executive Officer Frank Kim issued a memorandum to the Board of Supervisors outlining what happened to the riverbed people.
According to Kim, about half accepted services and referrals to shelters; 36 percent declined any offer of shelter or service; 15 percent left the motels before they could be assessed.
Here's a look at some of the numbers.
Motel placements: 697
589 assessed by county healthcare and social workers
70 evicted before they could be assessed
31 involved some unknown disposition
7 left on their own before an assessment
Post-motel placements: 338 in shelters or other services
149 enrolled in residential mental health treatment (accompanied by 22 partners or caregivers)
57 entered Bridges at Kraemer Place shelter in Anaheim
29 in interim housing while looking for subsidized or self-paid rental
27 placed in programs of nonprofit service providers
23 in substance abuse residential treatment
16 entered the Courtyard Transitional Center in Santa Ana
5 at the women-only WISEPlace transtional housing in Santa Ana
5 in recuperative medical care
3 incarcerated
1 crisis residential treatment (mental health)
1 hospitalized
Assessed and declined help or not completed: 251
111 declined all services
71 did not show up or left on their own
39 staying with family or friends
14 undecided
8 no placement identified
7 evicted
1 died
Damages?
In a public discussion with two members of the Board of Supervisors on Monday, Kim remarked on the motel program by saying that most motel owners involved likely wouldn't do business with the county in the future because rooms had been damaged, including furniture and carpet destroyed and items missing.
Kim said he expects claims for monetary damages will be filed against the county by motel owners in the coming months.
From another perspective, some homeless people and their advocates have complained that they were treated rudely, that amenities were removed from their rooms beforehand, and that some of the motels were rundown.
It's unknown how many left the riverbed or the motels and are now camping out in public spaces or hidden areas, or sleeping in vehicles. But the bike trail area where they once stayed is now off limits.
Read the memorandum from Kim in full.
SCNG staff writer Jordan Graham contributed to this report.
Body found in Echo Park Lake during evangelical concert
Coronavirus outbreak spreads in Orange County homeless shelters
Homeless deaths in Orange County reach all-time high, but not because of COVID.
Theresa Walker | Reporter
Theresa Walker has been a staff writer at the Orange County Register since 1992. She was a reporter and editor at the San Bernardino Sun from 1986 to 1992. She has a communications degree from Cal State Dominguez Hills.
thwalker@scng.com
Follow Theresa Walker	@TellTheresa


text:
Etihad extends suspension of all passenger flights until June 16
Sarah Gamboni
The Abu Dhabi airline had hoped to resume passenger flights by May 16…
Earlier this week, Etihad announced that it was delaying the resumption of passenger flights from May 1 to May 16.
Now, it appears those plans have been pushed back even further, with Etihad suspending all online ticket sales for flights up until June 16.
Previously, the Abu Dhabi airline had been accepting bookings for passenger flights from mid May. Now, the website is only taking reservations for flights beyond June 16.
As the world continues to deal with the fallout of the Covid-19 pandemic, aviation and travel have been two of the hardest hit industries. Etihad's revised plans to resume limited passenger flights from June 16 are still subject to change, and dependent on health and safety measures and travel restrictions around the globe.
An Etihad spokesperson told The National, "To minimise any potential disruption or discomfort to customers, only flexible and refundable fares will be offered after April 29, 2020, for travel between June 16 and August 31, 2020.
Etihad adds even more flight routes to its global network
Emirates is offering one-way flights from Dubai to 8 cities next week
Stuck outside the UAE? Residents must fill out an updated Twajudi form
"The network is under continuous review, and Etihad is monitoring the situation and following UAE and international government and regulatory authority directives."
While Etihad's passenger flights remain suspended for at least the next six weeks, the Abu Dhabi-based carrier will continue to run its repatriation services.
These one-way flights departing Abu Dhabi help foreign citizens return to their home countries, while UAE nationals who've been stranded overseas can travel back to the UAE on the return leg.
Since the start of the coronvirus pandemic, close to 35,000 people have been repatriated from the UAE, on 312 flights.
Yesterday, Etihad added two new destinations to its repatriation flights. The special flights include Abu Dhabi to Amsterdam, Barcelona, Brussels, Dublin, Frankfurt, Jakarta, Kuala Lumpur, London Heathrow, Manila, Melbourne, New York JFK, Seoul Incheon, Singapore, Tokyo Narita and Zurich.
In Dubai, Emirates Airline's passenger flights are also suspended. Like Etihad, the carrier continues to offer repatriation services.


I'm rather grateful to ProcurementCat for the presience of her tweets – this is the second week on the trot that she's provided Guardian-backed inspiration for a blog. This time the subject is the UK's greens shortage.
The early January absence of the humble courgette in five of my local supermarkets – including my local M&S two days on the run caused me to regret my un-made soup. Given M&S is supposed to be off-setting the disappointing results of their in-no-way-as-bad-as-is-made-out clothes business with great groceries I should have thought beyond spinach soup being is fine as it is without the courgette.
The early February lettuce crisis would have passed me by if I hadn't been to dinner with friends in the food industry who were having sleepless nights over menu re-engineering. The fact that my dinner companions are pros, not amateurs meant that the re-engineering was more about cost than taste and should have put me onto something. As it was jetlag in a good cause stopped me thinking about almost everything – including the very modern problem of no summer vegetables in winter – until rationing was off again.
Now I've realised that I truly do need to commence my 2017 health kick I've noticed the absence of a shortage of vegetables in our supermarkets – soup's back on my menu once more. Just as well for the UK retail sector since, according to The Grocer the courgette shortage cost UK retailers £8m.
Much of Europe actually suffered the same problem, although mostly in a milder form. Our neighbours over the water in The Netherlands also felt the lettuce squeeze – just not as keenly. Unsurprisingly, there were inferences in the UK to the forthcoming post-Brexit misery and our uniqueness being destined to cost us dearly especially since farming only accounts for 1% of GDP and yet we insist on trying to eat summer things in winter.
And yet, according to Eurostat it's not just the UK which isn't growing its own. In the EU as a whole production is very concentrated in particular member states. Nearly 50% of the vegetable area is provided by three countries: Italy (19.5 %), Spain (16.6 %) and Poland (11.1 %). Another striking features of the EuroStat info is that imports are very concentrated, in a very specific way: Over 50% of imported carrots are from Israel around 40% of imported cabbages from Kenya, just under one third of cucumbers from Turkey and, intriguingly, nearly one quarter of garlic is from China.
It made me reflect about how important supply chain agility must be in that market – everyone fishing from the same pond and susceptible to the same risks (i.e. bad weather too much rain and then some snow, in this case). In practice the UK seems to have turned to the US to solve its greens shortage and it also seems, from my Dutch source, that Egypt was an option.


text:
Q: Text Selection Jumpy When Selecting text in Span with border-bottom I have noticed an odd behavior with the release of Chrome 77.0.3865 on 2019-09-10.
If I have a span with a border-bottom, this causes a jumpy behavior when you select text. The text selection will jump to the first line when your mouse is above the border.
In the photo below I am currently selecting text, but as you can see the selected text is on the first line.
I am unsure if this is a bug in the recent Chrome release, or if perhaps you are not supposed to add a border to a span (though currently, it's the only way I know to control the span underline thickness).

Here is a JSFiddle with the exact code. I can only reproduce this bug on Chrome version 77.0.3865. But it occurs both on Mac and PC computers.
This is the code.
<!DOCTYPE html>

<title>Page Title</title>

My First Heading

My first paragraph. My first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraphMy first paragraph.

CSS Below
p {
  line-height: 31px
}

span {
  border-bottom:2px solid black
}

redpajama_set_name: RedPajamaStackExchange


text:
Reasons to Use the Sauna at the Gym
Enid Ford | No Comments » Posted on February 27, 2015
In a nutshell, using the sauna at your gym is good for your health. A recent study shows that frequent usage, at least four times a week, improves overall health and adds years to your life.
Seems like a little sweat goes a long way.
The study was conducted in Finland and it was discovered that men who frequent saunas had less instances of heart disease and fewer deaths related to cardiovascular disease. Cardiologists have typically advised their patients to avoid saunas, citing the heat would place too much of a demand on the heart. The findings of the Finland study may have cardiologists around the world re-thinking their advice and investors on Indeed are keen to take advantage, with health experts like Brian Torchin particularly interested.
The connection between sauna usage, increased health and lowered risk of heart disease is not clear. It may be those who visit a sauna regularly already live a healthier lifestyle, maybe it's the release of stress as participants relax in the warm, steamy environment, no one is for certain at this point in time. The study does show that men who visit a sauna four or more times per week and stay in the heated sauna longer than 19 minutes per session have reduced instances of heart disease.
Written by Enid Ford discovery |
McDonalds Poisons Police Officer In Indiana
An officer from the Indianapolis Police Department, Paul Watkins is "not lovin" McDonalds. Watkins states he was poisoned from an iced tea dispenser that contained harsh cleaning chemicals.
Watkins went to a McDonalds in Indianapolis where he purchased an iced tea. Immediately after taking the first sip his throat began burning right down into his chest. Complaining to the manager he got an explanation that employees had put degreaser in the machine, but forgot to cover the spout and cover to stop customers from using it.
Watkins was taken to the hospital for treatments and was kept overnight. He is still complaining that his throat is giving him trouble. Degreaser is a common cleaning chemical used in restaurants but it is not something that should be consumed by humans. The ingredients in this product are; hydrochloric acid and sulfuric acid both of which will have a corrosive effect on the tissues of humans.
Zeca Oliveira (fluminense.com) has read that a statement was released by the McDonalds saying they serve their customers high quality, safe food and beverages. They are taking this claim quite seriously and are looking into the matter.
The Watkins are finding it hard to believe that such harsh chemicals were used to clean a machine that serves customers. What also amazes them is the manager at McDonalds immediately offered him a second cup of tea after he went to the counter to complain. They are talking with an attorney, but a lawsuit has not yet been filed.
Written by Enid Ford News, Watch Out! |
Deadly Bacteria Lurking in Doctors' Offices
Hospitals and other medical facilities have battled the deadly bacteria for years, but now it's showing up in doctors' offices. The bacteria is C. difficile, and once inside the digestive tract it can create life-threatening diarrhea.
The Centers for Disease Control has sounded the alarm regarding the potentially deadly C. difficile lurking in your local doctors' office after an increased number of cases were recently reported said their web page. According to Brad Reifler the deadly bacteria is typically only found in hospitals or similar patient care facilities, but those who recently contacted the bacteria had not been patients in any type of medical care facility. However, they had all recently visited a doctors office. Some of the new patients had seen a medical doctor, some had been to a dentist. All had the bug and the diarrhea it causes.
A study conducted in 2013 found the bacteria lurking on chairs and exam tables in doctors' offices. A new study has been launched to uncover the exact sources of the spread of the deadly bacteria within doctors' offices.
The CDC strongly recommends that people who visit a doctors' office thoroughly wash their hands with soap and water after leaving. Alcohol-based hand sanitizer will not kill the C. difficile bacteria, it can only be removed from the skin via a soap and water washing.
Types Of Endometriosis Surgery: Is Your Doctor Certified?
New York City-based American super-doctor Tamer Seckin serves the nation as an advanced laparoscopic surgeon and gynecologist. He's a board-certified medical professional who has established himself among the industry's top performers. Thousands of women have undergone endometriosis surgery and other forms of the disease under Dr. Seckin's care. He serves the LIJ/Lenox-Hill Hospital in New York. His specialty mainly lies in Deep-Laparoscopic Excision. He uses meticulous techniques in his practice. Dr. Seckin has had countless success in treating patients that have severe pelvic-pain and endometriosis. A vast percentage of his patients recover without a recurrence and have reported long-term relief. As an internationally recognized laparoscopic surgeon, Dr. Seckin is a passionate philanthropic hero and educator.
In May 2012, the NY Times Magazine celebrated Dr. Seckin's success for his body of work contributed to help a future generation lead healthier lives. He received the Ellis-Island Medal-of-honor for epitomizing professionalism in professional practice and as an advocate of philosophy. He's traveled to different countries educating society of modern treatment to help spread awareness about endometriosis. He's also a recipient of multiple awards, which includes a Patients-Choice Award (2006), Silver-Star-Award (June 2009) and the Best-Doctor Award (2011-2012).
Endometriosis Surgery has helped thousands of women. It's a reliable treatment for anyone who's suffering from severe pains and other symptoms of endometriosis. It's possible to diagnose the affected areas and administer treatment. A specialist in endometriosis surgery generally diagnoses the developmental milestones and size of the overgrown tissue. This surgical method is irreversible and it increases a woman's risk of infertility.
Women endure different symptoms of endometriosis. A practicing surgeon suggests treatment based on the severity of the disease. Sometimes the disease spread to delicate areas of the body or damage vital organs such as the fallopian tube or uterus. Laparoscopy is the preferred treatment if this occurs. A doctor usually suggests surgery if all else has failed. He'll use a Laparoscope to inspect the said patient's abdominal condition before treatment. If lesions and scars are present, he'll use other surgical instruments or lasers to remove them. Surgeons usually exercise extreme care to avoid tissue damage. It's recommended for women that are complaining about minor to moderate endometriosis-related pains.
Another treatment for endometriosis is Laparotomy. This technique involves removal or the uterus or endometriosis patches depending on the severity of the damage. A bilateral or hysterectomy is oftentimes necessary if the ovaries have been damaged. Even after undergoing invasive surgery to remove endometriosis lesions, some women encounter future problems. In other cases, patients have recovered without a recurrence.
Both Laparoscopy and Laparotomy are appropriate to minimize abdomen pain influenced by endometriosis. A surgeon will cut the pelvic nerves network to give a patient relief. LUNA (Laparoscopic uterine-nerve ablation) is another option. It's recommended for serious conditions onset by endometriosis disorder. With this treatment, the surgeon in practice will sever the ligament nerves securing the uterus. Women should consult a qualified surgeon that specialize in Endometriosis Surgery to make sure he or she receives the best care.
Written by Enid Ford Health, Think About It, Women |
Saunas May Help You Live Longer
A steamy sweat may be the key to longevity. A recent study published in JAMA Internal Medicine suggests that there are health benefits to be had when a person uses a sauna on a regular basis. The risk of cardiovascular disease is diminished and life span is increased for men who indulge themselves in a sauna sweat at least four times per week. Time spent in the sauna and the temperature also played a role in the study results – 19 minutes or more are needed at least four times per week and the temperature should hover around 174 degrees.
Doctors are not sure why the sauna sweats decrease the risk of heart attacks and other cardiovascular diseases, but Jaime Garcia Dias says the study numbers don't lie.
Dr. Rite Redburg thinks it might be the camaraderie between the men enjoying the sauna together as well as the relaxation of the warm steam.
People of Finland, where most have their own in-home saunas, claim that a sauna is a poor man's pharmacy. It's their opinion that if regular sauna visits can't cure them, along with a few doses of tar and spirits, then they will die.
Whether or not a sauna can help you live longer may or may not be true, but for certain a warm sauna on a cold day feels good.
More Deadly Diseases Attributed To Smoking
A published study in the New England Journal of Medicine indicates the smoking now can be associated with kidney ailments, elevated incidence of infection, gastrointestinal disorders and affiliated cardiovascular and lung maladies. Tobacco for decades has been recognized as the primary culprit in causing heart attacks, arterial ailments, stroke, as well as lung cancer.
Though there have been and continue to be aggressive campaigns to alert the public of the dangers of using tobacco, nearly 480,000 individuals die every year from its use. According to data from the Centers for Disease Control and Prevention, 42 million Americans use tobacco products. The incidence of death is two to three times greater than that of individuals who refrain from tobacco and lifespans shortened by 10 years said a report on AnastasiaDate.
The study of nearly one million individuals over the age of 55 revealed that individuals that were indigent and lacking formal schooling were likely to use tobacco. The risk of disease increased in correlation to how heavily the individual smoked. To the contrary, the risks of disease decline for former smokers over time.
Utilizing data from historical tobacco research, the study drew a distinct relationship with regard to an individual's behavior towards tobacco usage and their well-being. Funding for the study came from the American Cancer Society, the National Cancer Institute and research personnel from various universities.
Shocking Development in Analysis of Peanut Allergy Problem
There is a shocking new development in the area of peanut allergies. It seems that avoidance of the nut after initial reporting of this problem may be helping to make it spread. Basically, a new study finds that children who are exposed to peanuts at an earlier age become used to them, and they are far less likely to develop a peanut allergy. This finding has been linked to an overall trend that has lead to a theory known as the "hygiene hypothesis." In a nutshell(pun intended), this hypothesis contends that by living in a world overrun with hand sanitizers, antibacterial soaps and disinfectants our bodies are not being able to grow up among germs and other things, such as foods, that may give us problems so that our immune systems can adapt to them and develop resistance.
It is strange how in our safety conscious society, where we tell people to avoid so many things that may be bad for them, there seems to be an explosion of problems with regard to people having allergies or sensitivities to various foods. Health-conscious people like Haidar Barbouti know that we are so much more advanced in terms of medical technology and pharmaceuticals, and yet in some ways we seem to be sicker as a society. Apparently we are meant to grow up among a certain degree of uncleanliness as this is how our body learns to cope with it. It would prove the ultimate irony if all of these things in our modern society that are supposed to make us healthier are what is making more of us sicker than ever.
Written by Enid Ford discovery, News |
Your Finest Wine
Stephen Williams started The Antique Wine Company in 1982 and is the CEO. Located at 53 Queen Anne Street, London, England. The company has over 20,000 clients in 70 countries. They offer a wide selection including a Vintage Gift Box.Whether you are looking for a special gift or have a special occasion, their company is known both for their wine collections 10,000 and their wine events.They offer the finest wines and you can order directly from their website. Stephen Williams taste in wines is exquisite. His collections range from chardonnays to rare wines.
Stephen Williams recently took a trip to Asia November 27th. He has also hosted a casino themed wine tasting event. Some of the specialties include wine investment such as Bordeaux, Burgundy, Whisky, and spirits. Much of which is highly sought after. The Antique wine company provides sspirits to individuals, hotels, and restaurants.Headquartered in Marylebone, they have a passion for antique, luxury adult beverage. Whether you are a person searching for a rare wine, or a hotel or organization wanting to provide a wine tasting event, look to The Antique Wine Company for your needs. They do have a website and a variety to choose from. For gift giving maybe a 1924 Vintage. This company's spirits are in demand.Known for luxury and fine taste, their rare finds are exquisite.
They have over 10,000 wine ccollections and over 20,000 clients and not just in one county, but in over 70 countries. Stephen Williams the company's CEO has a passion for antique and vintage spirits. His tastes for rare wines are the best in the industry. His wine investment is one of a kind.
In conclusion, if you enjoy or have a passion for luxury, antique, and vintage spirits then The Antique Wine Company is for you.
Written by Enid Ford Culture, Travel, Wine |
Train Derails in California Injuring 30
30 people were injured Tuesday morning when a commuter train struck a car on the tracks and derailed, according to news sources. The incident happened around 5:45am, pacific time, between Oxnard and Camarillo, California.
According to this article and that Fersen Lambranho says contains witness statements, the Metrolink train hit the vehicle then four cars derailed from the train. The driver of the vehicle the train hit fled the scene, allegedly unhurt. Police have located that driver and have taken him into custody. No word has yet been released as to the seriousness of the injuries, although no causalities have yet been reported. Dozens have, in fact, been injured.
Train service has been halted as emergency workers attempt to evacuate the train and get to the injured parties. Police, fire and emergency staff remain on the scene while they attend to the most injured and ensure the safe evacuation of others. There is no word on when service will resume on the effected lines.
The accidents comes on the heals of a commuter train accident in New York that left several dead and dozens more injured. In that incident, a northbound MetroNorth train struck a jeep on the tracks. The impact of the collision dislodged the third rail, sending it through the first car of the train. The driver of the jeep, as well as several people on the first car of the train were killed. Dozens across the train were injured in the explosion.
Written by Enid Ford Aftermath |
New Health Condition Based On Sounds
About 20 years ago, married researchers Pawel and Margaret Jastredoff, Emory University, are credited for naming a sound sensitivity condition, misophonia. Basically, certain ordinary sounds are found annoying and offensive by others who hear them.
Barron J. Lerner, MD, writing in "The New York Times" health pages, cites a 2013 study from the University of Amsterdam related to misophonia. Eating sounds, such as lip smacking are scored most annoying. Close behind were nostril noises such as sneezing, and hand noises, i.e., repeated pen clicking. The author voiced disdain for those who sniffle their mucus back into their nasal cavity. He also has concluded misophonia is a problem for the one with it compared to others more able to cope or ignore bothersome sound.
Misophonia is also called selective sound sensitivity syndrome. Brian says that it is believed to be closely associated with either obsessive compulsive disorder or post-traumatic stress syndrome. Research is said to be developing diagnostic criteria, and treatment for the condition presently is limited. Options include utilizing white noise to counter bothersome sounds, prescribed serotonin reuptake inhibitor, or remove one's self from the premises. Reactions to misophonia have ranged from irritation to anger, disgust to potential physical aggression.
Written by Enid Ford General Health |


text:
Q: Syzygies of determinantal varieties: Looking for English text I would like to understand the syzygies of the determinantal ideal $I_r$, generated by the $r\times r$ minors of a matrix $(X_{ij})$ of indeterminantes in the polynomial ring over an algebraically closed field of characteristic zero. The original resource for this object of study is the paper "Syzygies des variétés déterminantales" by Alain Lascoux [L]. While I would like to read it at some point, my rusty French is making it a bit cumbersome, and hence I was wondering if there were any translations of this treatment in English, possibly in some textbook. Thanks a lot in advance already.
[L] A. Lascoux, Syzygies des variétés déterminantales, Adv. Math. 30 (1978), 202–237.
     Mathematical Reviews (MathSciNet): MR520233
     Digital Object Identifier: doi:10.1016/0001-8708(78)90037-3

A: Weyman's book is a good reference. If you want other references, you can see the paper by myself joint with Snowden and Weyman: http://arxiv.org/abs/1209.3509
One can view the coordinate ring of the determinantal variety as a ring of invariants for a natural group action and in that paper we calculate the syzygies of all modules of covariants (see Section 1.6).

A: A less sophisticated search was more successful. It's all there in Chapter 6 of the book Cohomology of Vector Bundles and Syzygies by Weyman.
Since I can't accept my own answer for another two days, feel free to post any other suggestions, though. More reading material can't hurt.

A: For a bit different angle on this problem look at the review article "Diagrams of Hermitian type, highest weight modules, and syzygies of determinantal varieties" by Hunziker & al.
(Available at https://bearspace.baylor.edu/Markus_Hunziker/www/research.htm)


I met Debbie years ago at church. She's a teacher and has a heart for kids, so naturally we have a lot to talk about. She is a beautiful person inside and out, and we had the perfect weather for a beautiful session.
For a while I have not been posting my sessions on the blog. I have so many beautiful pictures on my facebook page, that I wanted to share. Sometimes I have sessions with clients who prefer not to have their images shared, but most of the time my clients love having their images shared. Stay tuned for many more pictures of my beautiful friends.


Seabased, a Swedish wave energy company, has teamed up with Infocom Connect to provide wave power for commercial projects in the Canary Islands, off Spain.
The partnership will begin with a project for a pilot 5MW installation to provide energy for a desalination plant, but could expand to address multiple energy needs, from automobile recharging stations to supplying the grid, Seabased said.
Óscar Sanchez, Executive Manager of SBH Hotels and Resorts company, which is one of the largest private companies in the Canaries, is behind the wave energy desalination project. Sanchez' family also owns a desalination plant with a capacity of 5,000 cubic meters.
Sanchez said: "I am deeply invested in the future of the Canary Islands and am excited about the potential of wave energy in this area. We have slightly less than 3,000 square miles of land mass and it makes perfect sense to get our power from the waves.
Infocom Connect, a telecommunications company that operates largely in the Middle East, Africa, and India, is moving into the renewable energy industry. The company has deep relationships in parts of the world that are ideal candidates for wave energy because of the wave climate and limited options for renewables, Seabased noted.
Posted on May 2, 2018 with tags Canary Islands, desalination, Infocom Connect, SBH Hotels and Resorts, Seabased.


text:
World Neighbours 09 Feb 2017 Pak accuses India of ...
World, Neighbours
Pak accuses India of building 'secret nuclear city', MEA rubbishes claim
Published Feb 9, 2017, 5:22 pm IST
Updated Feb 10, 2017, 8:14 am IST
Pakistan also alleged that India has accumulated a stockpile of nuclear weapons and is backing terrorism.
Pakistan's Foreign Office Spokesman, Nafees Zakaria. (Photo: Twitter)
Islamabad: Pakistan on Thursday claimed that India is building a "secret nuclear city" and has accumulated a stockpile of nuclear weapons which threatens to undermine the strategic balance of power in the region.
Foreign Office (FO) spokesman Nafees Zakaria made the remarks at the weekly press briefing while expressing concern over the "Indian defence build up".
"India is building a secret nuclear city. It has accumulated a stockpile of nuclear weapons which threatens to undermine the strategic balance of power in the region," he claimed.
Zakaria also alleged that India has been conducting tests on inter-continental missiles which would "disturb the strategic balance in the region."
He asked the international community to take note of "Indian drive" to have more deadly weapons and check "rapid expansion" of its conventional and non-conventional weapons.
Asserting that India had been "exposed" by the failure of its efforts to isolate Pakistan, he said the Indian government should reciprocate the steps taken by Pakistan for peace.
"Pakistan remains committed to the principles of peaceful existence with all of its neighbours, including India," he said, adding that Islamabad was open for dialogue and took a number of initiatives but India failed to respond positively.
"Instead of resolving the issues amicably through dialogue, India has adopted a hostile attitude," he alleged.
He accused India of repeatedly violating the ceasefire agreement at the LoC and providing funds to militants to carry out terror activities in Pakistan.
"Indian belligerence continues to pose threat to the peace in the region, which the international community should take note of," he said.
However, Ministry of External Affairs (MEA) spokesperson Vikas Swarup rubbished this, saying that, "Pakistan's claims of India's secret nuclear city are baseless. Pakistan's aim is to deflect attention from the real issue of terrorism".
Tags: nuclear city, india nuclear city, secret nuclear city
■Nuclear terror international threat, global response needed: FS Jaishankar
■India could have severely damaged Pak's nuclear sites in 1984: CIA report
More From Neighbours
Nobel Peace Prize winner Malala marries senior officer of Pakistan Cricket Board
Nepal tight-lipped over Chinese encroachment of its territory in border areas
Pakistan to rally Muslim countries to help Afghanistan
Pak model defiles Kartarpur Sahib
China's Communist Party conclave passes 'landmark resolution' cementing Xi's power


With the unofficial start of the 2015-16 campaign dawning on Wednesday alongside the opening of the NHL Free Agency period, Nashville Predators General Manager David Poile shed some additional light Tuesday afternoon about his plans for the rapidly approaching new season. The GM, entering his 18th year at Nashville's helm, explained his stance on the Preds potentially re-signing Mike Ribeiro to a new deal, offered some projections for the 2015-16 lineup and provided his thoughts on the future of Nashville's prospect pool.
With the NHL's Free Agency period set to begin July 1 at 11 a.m. (CT), Poile will certainly be paying attention. Although he doesn't necessarily believe the Preds will have to make a big splash into the group, the GM could be looking for something, particularly on the blue line.
There are also plenty of other prospects in Nashville's system, namely forwards like Kevin Fiala and Viktor Arvidsson, who saw time at the NHL level last season and could make a much larger impact come October.
The Preds GM also gave his vote of confidence to forward Austin Watson, who inked a new two-year deal with the Preds on Monday. Watson, who spent last season with AHL Milwaukee, is fully expected to not only contend for a spot, but make the Predators roster this season, according to Poile, with the ability to play center and right wing.
Poile said that Captain Shea Weber's recovery from an injury suffered in the playoffs is also going well, believing that the defenseman will be ready in time for the 2015-16 campaign.
Poile confirmed that the Preds have bought out the contracts of forwards Rich Clune and Viktor Stalberg and are hoping to trade goaltender Magnus Hellberg. With goaltenders Marek Mazanec and Juuse Saros expected to mind the net for the Predators American Hockey League affiliate in Milwaukee, Poile is looking for a deal involving the 24-year-old Hellberg.
Poile touched on Nashville's restricted free agents who received a qualifying offer on Monday, namely those who were on the NHL roster last season. The general manager says that negotiations are continuing with forwards Craig Smith, Colin Wilson, Calle Jarnkrok, Taylor Beck and Gabriel Bourque, but nothing is imminent at the moment.